BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 21136065)

  • 21. The molecular and genetic basis of fibroblast growth factor receptor 3 disorders: the achondroplasia family of skeletal dysplasias, Muenke craniosynostosis, and Crouzon syndrome with acanthosis nigricans.
    Vajo Z; Francomano CA; Wilkin DJ
    Endocr Rev; 2000 Feb; 21(1):23-39. PubMed ID: 10696568
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Crouzonodermoskeletal syndrome.
    Jeftha A; Stephen L; Morkel JA; Beighton P
    J Clin Pediatr Dent; 2004; 28(2):173-6. PubMed ID: 14969379
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Familial acanthosis nigricans with the FGFR3 mutation: Differences of pigmentation between male and female patients.
    Yasuda M; Morimoto N; Shimizu A; Toyoshima T; Yokoyama Y; Ishikawa O
    J Dermatol; 2018 Nov; 45(11):1357-1361. PubMed ID: 30168875
    [TBL] [Abstract][Full Text] [Related]  

  • 24. FGFR3 mutations and the skin: report of a patient with a FGFR3 gene mutation, acanthosis nigricans, hypochondroplasia and hyperinsulinemia and review of the literature.
    Blomberg M; Jeppesen EM; Skovby F; Benfeldt E
    Dermatology; 2010; 220(4):297-305. PubMed ID: 20453470
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Crouzon syndrome with periapical cemental dysplasia and acanthosis nigricans: the pleiotropic effect of a single gene?
    Suslak L; Glista B; Gertzman GB; Lieberman L; Schwartz RA; Desposito F
    Birth Defects Orig Artic Ser; 1985; 21(2):127-34. PubMed ID: 4041575
    [No Abstract]   [Full Text] [Related]  

  • 26. Topical sirolimus therapy for epidermal nevus with features of acanthosis nigricans.
    Dodds M; Maguiness S
    Pediatr Dermatol; 2019 Jul; 36(4):554-555. PubMed ID: 30983034
    [TBL] [Abstract][Full Text] [Related]  

  • 27. FGFR3 overactivation in the brain is responsible for memory impairments in Crouzon syndrome mouse model.
    Cornille M; Moriceau S; Khonsari RH; Heuzé Y; Loisay L; Boitez V; Morice A; Arnaud E; Collet C; Bensidhoum M; Kaci N; Boddaert N; Paternoster G; Rauschendorfer T; Werner S; Mansour SL; Di Rocco F; Oury F; Legeai-Mallet L
    J Exp Med; 2022 Apr; 219(4):. PubMed ID: 35254402
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Acanthosis nigricans in a Chinese girl with FGFR3 K650 T mutation: a case report and literature review.
    Fu J; Zhao Y; Wang T; Zhang Q; Xiao X
    BMC Med Genet; 2019 Jan; 20(1):8. PubMed ID: 30635042
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Case of a Japanese female presenting severe achondroplasia with developmental delay and acanthosis nigricans (SADDAN) syndrome with a K650M mutation in the fibroblast growth factor receptor 3 gene].
    Adachi M
    No To Hattatsu; 2008 Nov; 40(6):478-82. PubMed ID: 19039991
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Acanthosis nigricans and hypochondroplasia in a child with a K650Q mutation in FGFR3.
    Berk DR; Boente Mdel C; Montanari D; Toloza MG; Primc NB; Prado MI; Bayliss SJ; Pique LM; Schrijver I
    Pediatr Dermatol; 2010; 27(6):664-6. PubMed ID: 21510009
    [TBL] [Abstract][Full Text] [Related]  

  • 31. An unusual association of acanthosis nigricans and Crouzon's disease--a case report.
    Reddy BS; Garg BR; Padiyar NV; Krishnaram AS
    J Dermatol; 1985 Feb; 12(1):85-90. PubMed ID: 3894462
    [No Abstract]   [Full Text] [Related]  

  • 32. Characterization of membrane protein interactions in plasma membrane derived vesicles with quantitative imaging Förster resonance energy transfer.
    Sarabipour S; Del Piccolo N; Hristova K
    Acc Chem Res; 2015 Aug; 48(8):2262-9. PubMed ID: 26244699
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Familial hypochondroplasia and acanthosis nigricans with FGFR3 K650T mutation.
    Cossiez Cacard MA; Coulombe J; Bernard P; Kaci N; Bressieux JM; Souchon PF; Motte J; Legeai-Mallet L; Hadj-Rabia S; Eschard C
    J Eur Acad Dermatol Venereol; 2016 May; 30(5):897-8. PubMed ID: 25809207
    [No Abstract]   [Full Text] [Related]  

  • 34. Mosaic mutations in FGFR3 and FGFR2 are associated with naevoid acanthosis nigricans or RAVEN (round and velvety epidermal naevus).
    Larsabal M; Cogrel O; Caumont C; Jegou MH; Taïeb A; Morice-Picard F
    Br J Dermatol; 2019 Jan; 180(1):201-202. PubMed ID: 30117157
    [No Abstract]   [Full Text] [Related]  

  • 35. Autosomal dominant familial acanthosis nigricans caused by a C-terminal nonsense mutation of FGFR3.
    Tahara U; Yasuda M; Yamada Y; Aoki S; Sato S; Amagai M; Kubo A
    J Hum Genet; 2021 Aug; 66(8):831-834. PubMed ID: 33580140
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of glycolic acid peeling on the cutaneous manifestation of generalized acanthosis nigricans caused by FGFR3 mutation: A report of one sporadic and two familial cases.
    Ichiyama S; Kubo A; Matayoshi T; Saeki H; Funasaka Y
    J Dermatol; 2017 Oct; 44(10):e250-e251. PubMed ID: 28620983
    [No Abstract]   [Full Text] [Related]  

  • 37. Acanthosis nigricans in a child with mild osteochondrodysplasia and K650Q mutation in the FGFR3 gene.
    Leroy JG; Nuytinck L; Lambert J; Naeyaert JM; Mortier GR
    Am J Med Genet A; 2007 Dec; 143A(24):3144-9. PubMed ID: 18000903
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Crouzon Syndrome and Acanthosis Nigricans With Fibrous Dysplasia of the Maxilla: An Unreported Suggested Triad.
    Olshinka A; Tal D; Gillman L; Ad-El D; Kalish E; Kropach N; Yaacobi DS; Kornreich L; Staffenberg DA
    J Craniofac Surg; 2021 Jan-Feb 01; 32(1):310-312. PubMed ID: 33156176
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Nevoid acanthosis nigricans or RAVEN (rounded and velvety epidermal nevus): three cases].
    Petit A; Lemarchand-Venencie F; Pinquier L; Lebbe C; Bourrat E
    Ann Dermatol Venereol; 2012 Mar; 139(3):183-8. PubMed ID: 22401682
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hypochondroplasia and Acanthosis nigricans: a new syndrome due to the p.Lys650Thr mutation in the fibroblast growth factor receptor 3 gene?
    Castro-Feijóo L; Loidi L; Vidal A; Parajes S; Rosón E; Alvarez A; Cabanas P; Barreiro J; Alonso A; Domínguez F; Pombo M
    Eur J Endocrinol; 2008 Sep; 159(3):243-9. PubMed ID: 18583390
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.